查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲显影剂与注射器系统市场：分析与预测（2022-2026）
市场调查报告书
商品编码
1439032

欧洲显影剂与注射器系统市场：分析与预测（2022-2026）

Europe Contrast Media Agent and Injector System Market: Analysis and Forecast: 2022-2026
出版日期: | 出版商: BIS Research | 英文 94 Pages | 商品交期: 1-5个工作天内

价格

欧洲显影剂和注射系统市场规模预计将从 2022 年的 21.415 亿美元增长到 2026 年的 27.406 亿美元，预测期内复合年增长率为 6.36%。我是。

欧洲显影剂和注射器系统市场：简介

主要市场统计数据
预测期 2022-2026
2022年评估 21.415 亿美元
2026年预测 27.406 亿美元
复合年增长率 6.36%

在慢性病的增加、诊断影像需求的增加以及医学影像技术的进步等因素的推动下，欧洲显影剂和注射系统市场正在经历强劲成长。显影剂和注射器系统在提高电脑断层扫描、MRI 扫描和血管造影术等诊断影像中解剖结构的可见度方面发挥着重要作用。随着社会老化和医疗费用的增加，疾病的早期发现和准确诊断变得越来越重要，欧洲对显影剂和注射系统的需求不断增加。此外，旨在改善诊断影像技术和患者预后的研发正在取得进展，预计将成为市场成长的驱动力。旨在确保患者安全和提供创新成像解决方案的监管措施也促进了该地区的市场成长。

本报告调查了欧洲显影剂和注射系统市场，总结了市场概况、法律制度、专利趋势、市场影响因素分析、市场规模趋势和预测、竞争形势以及主要企业分析。

市场分类

细分 1：依产品分类

  • 显影剂
  • 注射系统

细分：喷射器系统（依产品）

  • 注射器
  • 耗材/配件

细分 2：按国家/地区

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他的

目录

执行摘要

调查范围

第一章 市场

  • 市场展望
    • 产品定义
    • 纳入与排除标准
    • 主要发现
  • 市场概况
  • 产业展望
    • 监管和法律要求及框架
    • 专利分析
    • 主要趋势
  • COVID-19 对显影剂和注射器系统市场的影响
  • 市场动态
    • 影响分析
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 区域

  • 概述
  • 欧洲
    • 主要发现
    • 市场动态
    • 市场规模/预测

第三章市场－竞争基准化分析与公司概况

  • 竞争基准化分析
    • 主要策略及发展
    • 市场占有率分析
  • 显影剂生态系中的活跃公司
  • 公司简介
    • Bayer AG
    • Bracco Group
    • Fresenius SE & Co. KGaA
    • Guerbet
    • ulrich GmbH & Co. KG
Product Code: BHR1891SS

The Europe Contrast Media Agent and Injector System Market Expected to Reach $2,740.6 Million by 2026

Introduction to Europe Contrast Media Agent and Injector System Market

KEY MARKET STATISTICS
Forecast Period2022 - 2026
2022 Evaluation$2,141.5 Million
2026 Forecast$2,740.6 Million
CAGR6.36%

The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026. The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

Market Introduction

The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies. Contrast media agents and injector systems play a crucial role in enhancing the visibility of anatomical structures during imaging procedures such as CT scans, MRI scans, and angiography. With a growing aging population and rising healthcare expenditures, there is a heightened emphasis on early disease detection and accurate diagnosis, further fueling the demand for contrast media agents and injector systems in Europe. Additionally, ongoing research and development activities aimed at improving imaging techniques and patient outcomes are expected to drive market growth. Regulatory initiatives aimed at ensuring patient safety and the availability of innovative imaging solutions also contribute to market expansion in the region.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

Segmentation 2: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

  • Bayer AG
  • Bracco Group
  • Guerbet
  • ulrich GmbH & Co. KG

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Markets

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion and Exclusion Criteria
    • 1.1.3 Key Findings
  • 1.2 Market Overview
  • 1.3 Industry Outlook
    • 1.3.1 Regulatory and Legal Requirements and Framework
      • 1.3.1.1 Regulatory and Legal Requirements and Framework in Europe
    • 1.3.2 Patent Analysis
      • 1.3.2.1 Patent Filing Trend (by Year)
      • 1.3.2.2 Patent Filing Trend (by Country)
    • 1.3.3 Key Trends
      • 1.3.3.1 Nanoparticle-Based Contrast Agents
      • 1.3.3.2 Development of Safer Contrast Media Agent
      • 1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1 Pre-COVID-19 Impact
    • 1.4.2 During COVID-19 Impact
    • 1.4.3 Post-COVID-19 Impact
  • 1.5 Market Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Market Drivers
      • 1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3 Growing Number of Regulatory Approvals
    • 1.5.3 Market Restraints
      • 1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4 Market Opportunities
      • 1.5.4.1 IT Advances in Contrast Media Injectors

2 Region

  • 2.1 Overview
  • 2.2 Europe
    • 2.2.1 Key Findings
    • 2.2.2 Market Dynamics
      • 2.2.2.1 Impact Analysis
    • 2.2.3 Market Size and Forecast
      • 2.2.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.1.1 Europe Contrast Media Injector System Market (by Product)
      • 2.2.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
        • 2.2.3.2.1 Germany
          • 2.2.3.2.1.1 Market Sizing and Forecast
          • 2.2.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
        • 2.2.3.2.2 Italy
          • 2.2.3.2.2.1 Market Sizing and Forecast
          • 2.2.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
        • 2.2.3.2.3 France
          • 2.2.3.2.3.1 Market Sizing and Forecast
          • 2.2.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
        • 2.2.3.2.4 U.K.
          • 2.2.3.2.4.1 Market Sizing and Forecast
          • 2.2.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
        • 2.2.3.2.5 Spain
          • 2.2.3.2.5.1 Market Sizing and Forecast
          • 2.2.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
        • 2.2.3.2.6 Rest-of-Europe
          • 2.2.3.2.6.1 Market Sizing and Forecast
          • 2.2.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Benchmarking
    • 3.1.1 Key Strategies and Development
      • 3.1.1.1 Regulatory and Legal Activities
      • 3.1.1.2 Partnerships, Collaborations, and Business Expansions
      • 3.1.1.3 Mergers and Acquisitions
      • 3.1.1.4 New Offerings
    • 3.1.2 Market Share Analysis
      • 3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
      • 3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
  • 3.2 Contrast Media Ecosystem Active Players
  • 3.3 Company Profiles
    • 3.3.1 Bayer AG
      • 3.3.1.1 Company Overview
      • 3.3.1.2 Role of Bayer AG in the Contrast Media Agent and Injector System Market
      • 3.3.1.3 Financials
      • 3.3.1.4 Recent Developments
      • 3.3.1.5 Analyst Perception
    • 3.3.2 Bracco Group
      • 3.3.2.1 Company Overview
      • 3.3.2.2 Role of Bracco Group in the Contrast Media Agent and Injector System Market
      • 3.3.2.3 Recent Developments
      • 3.3.2.4 Analyst Perception
    • 3.3.3 Fresenius SE & Co. KGaA
      • 3.3.3.1 Company Overview
      • 3.3.3.2 Role of Fresenius SE & Co. KGaA in the Contrast Media Agent and Injector System Market
      • 3.3.3.3 Financials
      • 3.3.3.4 Recent Developments
      • 3.3.3.5 Analyst Perception
    • 3.3.4 Guerbet
      • 3.3.4.1 Company Overview
      • 3.3.4.2 Role of Guerbet in the Contrast Media Agent and Injector System Market
      • 3.3.4.3 Financials
      • 3.3.4.4 Recent Developments
      • 3.3.4.5 Analyst Perception
    • 3.3.5 ulrich GmbH & Co. KG
      • 3.3.5.1 Company Overview
      • 3.3.5.2 Role of ulrich GmbH & Co. KG in the Contrast Media Agent and Injector System Market
      • 3.3.5.3 Recent Developments
      • 3.3.5.4 Analyst Perception

List of Figures

  • Figure 1: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 10: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
  • Figure 11: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
  • Figure 12: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 13: Number of CT Scans Per One Million Inhabitants, 2018-2020
  • Figure 14: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
  • Figure 15: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 16: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 17: Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 18: Innovative Vendors Product Solutions
  • Figure 19: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 20: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 21: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 22: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 23: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 24: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 25: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 26: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 27: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 28: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 29: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 30: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 31: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 32: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 33: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
  • Figure 34: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 35: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 36: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 37: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
  • Figure 38: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 39: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 40: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
  • Figure 41: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
  • Figure 42: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 43: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 44: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 45: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 46: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 47: Mergers and Acquisitions, January 2018-May 2023
  • Figure 48: New Offerings, January 2018-May 2023
  • Figure 49: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 50: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 51: Bayer AG: Product Portfolio
  • Figure 52: Bayer AG: Overall Financials, $Million, 2020-2022
  • Figure 53: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 54: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
  • Figure 55: Bayer AG: R&D Expenditure, $Million, 2020-2022
  • Figure 56: Bracco Group: Product Portfolio
  • Figure 57: Fresenius SE & Co. KGaA: Product Portfolio
  • Figure 58: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
  • Figure 59: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
  • Figure 60: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 61: Guerbet: Product Portfolio
  • Figure 62: Guerbet: Overall Financials, $Million, 2020-2022
  • Figure 63: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 64: ulrich GmbH & Co. KG: Product Portfolio

List of Tables

  • Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Europe Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 8: Contrast Media Ecosystem Active Players